Novavax (NVAX)
(Delayed Data from NSDQ)
$4.15 USD
-0.04 (-0.95%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $4.14 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -1.04 |
EPS Last Quarter | -1.44 |
Last EPS Surprise | -193.88% |
ABR | 2.50 |
Earnings ESP
|
15.06% |
---|---|
Current Year | -0.83 |
Next Year | -0.07 |
EPS (TTM) | -5.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 101.24M | 97.96M | 863.95M | 1.03B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 104.23M | 152.00M | 941.80M | 1.61B |
Low Estimate | 99.80M | 75.00M | 808.00M | 634.70M |
Year ago Sales | 80.95M | 424.43M | 983.71M | 863.95M |
Year over Year Growth Est. | 25.06% | -76.92% | -12.17% | 19.55% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.04 | -0.80 | -0.83 | -0.07 |
# of Estimates | 5 | 5 | 7 | 7 |
Most Recent Consensus | -0.93 | -0.92 | -1.40 | -0.16 |
High Estimate | -0.85 | -0.53 | 0.13 | 1.66 |
Low Estimate | -1.48 | -1.23 | -1.65 | -1.23 |
Year ago EPS | -3.41 | 0.58 | -5.41 | -0.83 |
Year over Year Growth Est. | 69.50% | -237.93% | 84.66% | 91.57% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 0 | 4 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 4 | 0 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.04 | -0.80 | -0.83 | -0.07 |
7 Days Ago | -1.04 | -0.80 | -0.83 | -0.07 |
30 Days Ago | -1.07 | -0.83 | -0.88 | 0.08 |
60 Days Ago | -0.06 | -1.20 | -0.26 | 0.28 |
90 Days Ago | -0.21 | -0.99 | -0.69 | -0.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.88 | -0.53 | -1.28 | 1.66 |
Zacks Consensus Estimate | -1.04 | -0.80 | -0.83 | -0.07 |
Earnings ESP | 15.06% | 33.58% | -53.88% | 2,520.85% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.44 | -1.26 | 0.58 | -3.41 | NA |
Estimate | -0.49 | -1.82 | -1.24 | -3.38 | NA |
Difference | -0.95 | 0.56 | 1.82 | -0.03 | 0.35 |
Surprise | -193.88% | 30.77% | 146.77% | -0.89% | -4.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more